The Scientist

» top 10 innovations and disease/medicine

Most Recent

image: Double-Edged TB Drug

Double-Edged TB Drug

By | September 12, 2012

A cheap pain reliever that can kill drug-resistant, tuberculosis-causing bacteria may never be tested.

2 Comments

image: Lasker Winners Announced

Lasker Winners Announced

By | September 10, 2012

This year’s prizes are awarded for advances in liver transplantation, cell biology, and leadership in biomedical science.

0 Comments

image: Fears over Fast-Tracking Drugs

Fears over Fast-Tracking Drugs

By | September 10, 2012

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.

0 Comments

image: Robot Legs Obey Brain

Robot Legs Obey Brain

By | September 7, 2012

A pair of mechanical leg braces that are controlled by their wearer’s brain signals could help paralyzed patients walk again.

1 Comment

image: Pleasant to the Touch

Pleasant to the Touch

By | September 1, 2012

Scientists hope an understanding of nerve fibers responsive only to gentle touch will give insight into the role the sense plays in social bonding.

0 Comments

image: Opinion: Younger Is Better

Opinion: Younger Is Better

By | August 31, 2012

Stem cells collected from younger donors are more effective for transplantation and regenerative medicine than those from older individuals.

9 Comments

image: Dieting Monkeys Don't Live Longer

Dieting Monkeys Don't Live Longer

By | August 29, 2012

The latest news from a long-term study of calorie restriction in rhesus macaques shows better health, but no boost in lifespan, in monkeys who eat less.

11 Comments

image: Submit Your Innovations Today!

Submit Your Innovations Today!

By | August 29, 2012

You have until the end of this week (Sept. 21 @ 11:59 PM, EDT) to submit your product to The Scientist's 2012 Top 10 Innovations. Be sure to enter your innovative products!

0 Comments

image: Epigenetic Drug Improves Cholesterol Levels

Epigenetic Drug Improves Cholesterol Levels

By | August 28, 2012

Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.

1 Comment

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  3. How Microbes May Influence Our Behavior
  4. Do Microbes Trigger Alzheimer’s Disease?
AAAS